[Management of chemotherapy-induced anemia in lung cancer].
Fiche publication
Date publication
octobre 2015
Journal
Revue des maladies respiratoires
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CLEMENT-DUCHENE Christelle, Pr MARTINET Yves
Tous les auteurs :
Tiotiu A, Clément-Duchêne C, Martinet Y
Lien Pubmed
Résumé
The prevalence of chemotherapy-induced anemia in lung cancer is estimated at about 80%.
Mots clés
Anemia, chemically induced, Antineoplastic Agents, adverse effects, Biosimilar Pharmaceuticals, therapeutic use, Blood Transfusion, Clinical Trials as Topic, Combined Modality Therapy, Disease Management, Erythrocyte Transfusion, Fatigue, etiology, Hematinics, administration & dosage, Hemoglobins, analysis, Humans, Iron, therapeutic use, Lung Neoplasms, blood, Practice Guidelines as Topic, Quality of Life, Radiotherapy, adverse effects, Recombinant Proteins, therapeutic use
Référence
Rev Mal Respir. 2015 Oct;32(8):809-21